US2007258945A1PendingUtilityA1
G-GSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
Est. expiryOct 27, 2023(expired)· nominal 20-yr term from priority
A61P 9/10A61K 38/193
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.
Claims
exact text as granted — not AI-modified1 - 7 . (canceled)
8 . A kit containing components for treating myocardial infarction or occlusion in an artery comprised of:
a) a composition comprising G-CSF polypeptide; and b) optionally, at least one additional factor selected from the group consisting of: EPO, SCF, M-GDF, GM-CSF, M-CSF, CSF-1, IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-1, IL-11, IL-12, IGF-1, LIF, interferon, a neurotrophic factor, a fibroblast growth factor, and human growth hormone.
9 - 10 . (canceled)Join the waitlist — get patent alerts
Track US2007258945A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.